Skip to main content

RARE- Ultragenyx Pharmaceutical Inc.

Over the past 90 days, insiders at Ultragenyx Pharmaceutical Inc. (RARE) have been net sellers, shedding 4,653 shares worth roughly $111K on balance.

RARE sits in the Biotechnology industry within the Health Care sector, so this activity is best read against the sector's broader insider trend.

Compare Health Care sector insider flows →

Insider Ownership

RoleInsiderSharesValue30d
Other147.8K$3.80M-
Other133.1K$3.42M-
CEO132.7K$3.41M-
CFO105.7K$2.72M-
VP95.7K$2.46M-

Activity

Buys and sells only

Transactions

10 filings · page 21
DateInsiderRoleTypeSharesPriceValueChg%SEC
Jul 20, 2015Sharp ShaliniCFO &Senior Vice PresidentSell3,854$131.95$508,532.22-2.9%
Jul 20, 2015Sharp ShaliniCFO &Senior Vice PresidentSell3,854$131.95$508,532.22-2.9%
Jul 8, 2015Kassberg Thomas Richard68Cbo &Senior Vice PresidentSell3,334$102.12$340,468.08-4.3%
Jun 18, 2015Sharp ShaliniCFO &Senior Vice PresidentSell4,000$96.08$384,339.60-4.1%
Jun 17, 2015Huizenga Theodore Alan65Controller And PaoSale+OE1,500$94.80$142,200.00-37.5%
Jun 10, 2015Kassberg Thomas Richard68Cbo &Senior Vice PresidentSell3,334$88.19$294,025.46-4.2%
May 18, 2015Sharp ShaliniCFO &Senior Vice PresidentSell4,000$79.43$317,720.00-8.1%
May 13, 2015Kassberg Thomas Richard68Cbo &Senior Vice PresidentSell3,334$72.04$240,181.36-4.2%
Apr 20, 2015Sharp ShaliniCFO &Senior Vice PresidentSell4,000$62.23$248,910.00-3.9%
Apr 8, 2015Kassberg Thomas Richard68Cbo &Senior Vice PresidentSell3,333$58.02$193,380.66-4.0%

Understand these filings